Results
weight gain
The mean age of the participants was 51.1 ± 5.3 years. Most of the participants were female (52%), married (64%), and unemployed (82.6%) and had below diploma education levels (64%). More than half of the participants underwent hemodialysis three times a week (76%). The mean duration of hemodialysis treatment was 49.95 months. The results showed no significant difference between the two groups concerning the duration of the hemodialysis treatment (Comparison of the two groups regarding demographic and clinical dataBefore the intervention, the two groups were homogeneous regarding the mean scores of ESRD-AQ, laboratory tests, and hope. After the intervention, however, the intervention group showed a significant improvement in the mean score of treatment adherence, BUN level, phosphate level, and mean inter-dialytic weight gain compared to the control group. The mean score of hope was also higher in the intervention group (42.1 ± 6.1) compared to the control group (38.7 ± 6.5) after the intervention. However, no statistically significant difference was found between the two groups in term of potassium and creatinine levels after the intervention (Table Comparison of the two groups regarding treatment adherence, laboratory tests, inter-dialytic weight gain, and hope before and after the intervention*Paired t-test**Independent t-test